Generate a tailored SOP for Dr. Elena Rangelova. Improve your application with a focused, well-structured draft.
Elena Rangelova is a prominent researcher affiliated with the University of Gothenburg, specializing in pancreatic cancer. With extensive experience in clinical nutrition and surgical oncology, her research focuses on improving outcomes for patients undergoing pancreatic surgery, particularly in the context of neoadjuvant therapy and perioperative care. She has co-authored multiple significant studies addressing the challenges of managing locally advanced and borderline resectable pancreatic cancers. Dr. Rangelova's work includes contributions to systematic reviews and meta-analyses that analyze the effectiveness of various treatment strategies, such as FOLFIRINOX and gemcitabine-based chemotherapy, for patients facing complex surgical decisions. Additionally, her involvement in international collaborations reflects her dedication to enhancing understanding and refining approaches in the field of abdominal surgery, with an emphasis on improving patient selection, surgical outcomes, and postoperative care through evidence-based practices.
University of Gothenburg • Gothenburg, Sweden
Conducting research on surgical techniques and therapies for pancreatic cancer.
Administered by the Department of Political Science; focus on International Administration and Global Governance (IAGG).